Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Preliminary Mechanism Study of Modified Utral-long Protocol in Improving Endometrial Receptivity in Patients With PCOS and Insulin Resistance

NCT03100240 is registered in ClinicalTrials.gov with Reproductive & Genetic Hospital of CITIC-Xiangya as lead sponsor.

NCT NCT03100240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03100240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Preliminary Mechanism Study of Modified Utral-long Protocol in Improving Endometrial Receptivity in Patients With PCOS and Insulin Resistance
Lead sponsor
Reproductive & Genetic Hospital of CITIC-Xiangya
Phase
Not applicable
Overall status
Terminated
Start date
August 28, 2017
Completion date
September 30, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcos